...
首页> 外文期刊>Analytica chimica acta >Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: Urinary hexanal and heptanal as lung tumor biomarkers
【24h】

Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: Urinary hexanal and heptanal as lung tumor biomarkers

机译:固相微萃取-气相色谱-质谱法测定内源性物质的验证:尿己醛和庚醛作为肺部肿瘤的生物标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hexanal and heptanal are endogenous aldehydes coming from membrane lipid oxidation, found in lung cancer patients' blood, and suggested as lung tumor biomarkers. Here the urinary matrix was investigated instead of blood and the difficulties related to the determination of endogenous substances in biological matrices were faced by developing an external calibration HS-SPME/GC/MS method. The methodology was validated according to international validation procedures and it was verified analyzing unknown biological samples from cancer patients and healthy subjects. Percentage accuracy and precision, ranging from -11.25 to 10.85% and from 0.45 to 4.46%, respectively, were obtained, together with limits of detection (LODs) and lower limits of quantification (LLOQs) of 0.11 and 0.23 pg μL~(-1) for hexanal and of 0.10 and 0.21 pg μL~(-1) for heptanal. Analytes percentage recoveries (66.3%, hexanal and 70.5%, heptanal) and stability were evaluated. No analytes degradation was found at room temperature, while the remarkable analytes loss found after 1 month storage suggests analyzing biological samples within a week from storage. Results coming from the analysis of unknown biological samples showed no evident differences of heptanal urinary excretion between lung cancer patients and healthy subjects (0.22-0.95 and 0.21-0.69 pg μL~(-1), respectively), while hexanal urinary concentrations in cancer patients (0.24-4.36 pg μL~(-1)) were slightly higher than those found in control group ones (0.23-1.26 pg μL~(-1)). The obtained results highly suggest to do further investigations in order to collect statistically significant biological data to discriminate between the pathological state of lung cancer patients and physiological conditions of healthy subjects, using the simple, rapid and cheap method here reported for the quantification of urinary aldehydes.
机译:己醛和庚醛是来自膜脂质氧化的内源性醛,存在于肺癌患者的血液中,被建议作为肺肿瘤的生物标志物。在这里研究尿基质而不是血液,通过开发外部校准HS-SPME / GC / MS方法面临着与确定生物基质中内源性物质有关的困难。该方法已根据国际验证程序进行了验证,并通过分析来自癌症患者和健康受试者的未知生物样品而得到验证。获得的百分比准确度和精密度分别为-11.25%至10.85%和0.45%至4.46%,以及检测限(LOD)和定量下限(LLOQ)分别为0.11和0.23 pgμL〜(-1) )对于己醛而言为0.10和0.21 pgμL〜(-1)。评价了分析物的百分比回收率(66.3%,己醛和70.5%,庚醛)和稳定性。在室温下未发现分析物降解,而在储存1个月后发现显着的分析物损失表明储存后一周内对生物样品进行了分析。未知生物学样品的分析结果表明,肺癌患者和健康受试者的肝泌尿排泄无明显差异(分别为0.22-0.95和0.21-0.69 pgμL〜(-1)),而癌症患者的己醛尿浓度(0.24-4.36 pgμL〜(-1))略高于对照组(0.23-1.26 pgμL〜(-1))。获得的结果强烈建议进行进一步研究,以收集统计学上有意义的生物学数据,以区分肺癌患者的病理状态和健康受试者的生理状况,使用此处报道的简单,快速和廉价的尿醛定量方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号